FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 3499867 · Received December 2, 2013

Report

Report Number
2953161-2013-00184
Event Type
Injury
Date Received
December 2, 2013
Date of Event
November 2, 2013
Report Date
November 8, 2013
Manufacturer
W. L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICE VERIFIED THAT THE LOT MET ALL PRE-RELEASE SPECIFICATIONS.

Description of Event or Problem · 1

ON (B)(6) 2013, THE PATIENT UNDERWENT ENDOVASCULAR REPAIR OF A THORACIC AORTIC ANEURYSM AT THE AORTIC ARCH USING TWO GORE TAG THORACIC ENDOPROSTHESES AND THREE ILIAC EXTENDER COMPONENTS OF GORE EXCLUDER AAA ENDOPROSTHESIS. THE PHYSICIAN FIRST IMPLANTED (B)(4)DISTALLY AT THE DESCENDING AORTA THEN IMPLANTED (B)(4) PROXIMALLY AT THE AORTIC ARCH. IN ORDER TO PRESERVE THE BLOOD FLOWS INTO THE LEFT SUBCLAVIAN ARTERY, THE PHYSICIAN POKED HOLES ON THE SIDE WALL OF THE (B)(4) USING A "NEEDLE" ADVANCED FROM EACH BRANCH VESSEL AND IMPLANTED THE ILIAC EXTENDER COMPONENTS FROM EACH OF THREE VESSELS TO THE TGT 4015. THE FINAL ANGIOGRAM SHOWED NO ENDOLEAK AND THE PATENCY OF ALL THREE VESSELS. THE PROCEDURE CONCLUDED WITH NO COMPLICATIONS REPORTED. ON (B)(6) 2013, DIGITAL SUBTRACTION ANGIOGRAPHY (DS) IMAGES SHOWED THAT THE ILIAC EXTENDER COMPONENT ((B)(4)), WHICH WAS SUPPOSED TO BE DEPLOYED INSIDE THE (B)(4) FROM THE BRACHIOCEPHALIC ARTERY, WAS ACTUALLY DEPLOYED OUTSIDE THE (B)(4), PRESSED AGAINST THE AORTIC WALL. IN ORDER TO RESTORE THE BLOOD FLOW INTO THE BRACHIOCEPHALIC ARTERY, (B)(4) WAS EXTENDED WITH AN ADDITIONAL CONTRALATERAL LEG COMPONENT ((B)(4)) TO CREATE A "CHIMNEY." THE PATIENT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
623011 GORE EXCLUDER AAA ENDOPROSTHESIS MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES 11188871

Patients

Seq Age Sex Outcome Treatment
1 77 YR Hospitalization| L| R